Indeed, since the antidepressants’ suppression of platelet 5-HT uptake mirrors the inhibition of synaptic 5-HT uptake [41], it is rational to contemplate the potential use of peripheral serum, plasma, or platelet 5-HT as a biomarker for depression [42,43]. Here, HTR5A is linked to depressive symptom measurement.